Comparison of annual cost between brand and generic ocular beta-adrenergic blockers

3Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

We conducted a study of the annual cost of various ophthalmic products used in Japan for treating glaucoma including six of brands and generic ocular beta-adrenergic blockers (38 products). The total number of drops in one bottle of each solution was counted drop by drop. The cost per drop was calculated by dividing the government-controlled standard prices by the total number of drops in one bottle. The annual cost of ophthalmic solution was calculated by multiplying the cost per drop by the number of drops typically used per day. The total number of drops of the ophthalmic solutions in one bottle ranged from 108 to 168. The yearly cost of the beta-adrenergic blockers studied ranged widely, from ¥5392 to ¥27236. Differences in the total number of drops and the usage effect on the annual cost of ophthalmic solutions were found. The annual cost depended on not only the price of the products but also on the total number of drops in one bottle and the usage. Annual cost data may be helpful in selecting ophthalmic products for treating glaucoma in Japan. © 2005 The Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Ikeda, H., Tsukamoto, H., Sawa, A., Sugimoto, A., Mishima, H., & Kihira, K. (2005). Comparison of annual cost between brand and generic ocular beta-adrenergic blockers. Yakugaku Zasshi, 125(5), 463–467. https://doi.org/10.1248/yakushi.125.463

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free